de la Fuente JM - Search Results

1

A trial of carbamazepine in borderline personality disorder.

de la Fuente JM, Lotstra F. de la Fuente JM, et al. Eur Neuropsychopharmacol. 1994 Dec;4(4):479-86. doi: 10.1016/0924-977x(94)90296-8. Eur Neuropsychopharmacol. 1994. PMID: 7894258 Clinical Trial.

2

Temporal glucose metabolism in borderline personality disorder.

de la Fuente JM, Lotstra F, Goldman S, Biver F, Luxen A, Bidaut L, Stanus E, Mendlewicz J. de la Fuente JM, et al. Psychiatry Res. 1994 Dec;55(4):237-45. doi: 10.1016/0925-4927(94)90017-5. Psychiatry Res. 1994. PMID: 7701037

3

Altered frontostriatal relationship in unmedicated schizophrenic patients.

Biver F, Goldman S, Luxen A, Delvenne V, De Maertelaer V, De La Fuente J, Mendlewicz J, Lotstra F. Biver F, et al. Psychiatry Res. 1995 Sep 29;61(3):161-71. doi: 10.1016/0925-4927(95)02672-k. Psychiatry Res. 1995. PMID: 8545500

4

Electroencephalographic abnormalities in borderline personality disorder.

De la Fuente JM, Tugendhaft P, Mavroudakis N. De la Fuente JM, et al. Psychiatry Res. 1998 Feb 9;77(2):131-8. doi: 10.1016/s0165-1781(97)00149-2. Psychiatry Res. 1998. PMID: 9541149 Clinical Trial.

5

Effects of carbamazepine on dexamethasone suppression and sleep electroencephalography in borderline personality disorder.

De la Fuente JM, Bobes J, Vizuete C, Mendlewicz J. De la Fuente JM, et al. Neuropsychobiology. 2002;45(3):113-9. doi: 10.1159/000054948. Neuropsychobiology. 2002. PMID: 11979058 Clinical Trial.

6

TRH stimulation and dexamethasone suppression in borderline personality disorder.

De la Fuente JM, Mendlewicz J. De la Fuente JM, et al. Biol Psychiatry. 1996 Sep 1;40(5):412-8. doi: 10.1016/0006-3223(95)00394-0. Biol Psychiatry. 1996. PMID: 8874844 Clinical Trial.

7

Brain glucose metabolism in borderline personality disorder.

De La Fuente JM, Goldman S, Stanus E, Vizuete C, Morlán I, Bobes J, Mendlewicz J. De La Fuente JM, et al. J Psychiatr Res. 1997 Sep-Oct;31(5):531-41. doi: 10.1016/s0022-3956(97)00001-0. J Psychiatr Res. 1997. PMID: 9368195

8

Neurologic soft signs in borderline personality disorder.

De la Fuente JM, Bobes J, Vizuete C, Bascaran MT, Morlán I, Mendlewicz J. De la Fuente JM, et al. J Clin Psychiatry. 2006 Apr;67(4):541-6. doi: 10.4088/jcp.v67n0404. J Clin Psychiatry. 2006. PMID: 16669718

9

Biological nature of depressive symptoms in borderline personality disorder: endocrine comparison to recurrent brief and major depression.

De la Fuente JM, Bobes J, Vizuete C, Mendlewicz J. De la Fuente JM, et al. J Psychiatr Res. 2002 May-Jun;36(3):137-45. doi: 10.1016/s0022-3956(01)00056-5. J Psychiatr Res. 2002. PMID: 11886691

10

Sleep-EEG in borderline patients without concomitant major depression: a comparison with major depressives and normal control subjects.

De la Fuente JM, Bobes J, Vizuete C, Mendlewicz J. De la Fuente JM, et al. Psychiatry Res. 2001 Dec 15;105(1-2):87-95. doi: 10.1016/s0165-1781(01)00330-4. Psychiatry Res. 2001. PMID: 11740978

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

216 results

Search Page